Molecular classification based on immunohistochemical markers – estrogen receptor (ER), progesterone receptor (PR), and HER2 – divides breast cancers into distinct subtypes: luminal A, luminal B, HER2-enriched, and triple-negative [3]. This evidence concerns the gene PGR and breast cancer.